Global Psoriasis Therapeutics Market 2022 by Company, Regions, Type and Application, Forecast to 2028

Q: What are the significant segments operating in the market?

Market is segmented on the basis. Read More

Global Psoriasis Therapeutics Market 2022 by Company, Regions, Type and Application, Forecast to 2028

Report ID : 96283
Published On: Mar, 2022
Pages: 156
Pharmaceuticals and Healthcare

Buy @ $3500

The Psoriasis Therapeutics market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our latest study, due to COVID-19 pandemic, the global Psoriasis Therapeutics market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. Oral accounting for % of the Psoriasis Therapeutics global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While TNF Inhibitors segment is altered to a % CAGR between 2022 and 2028.

Global key companies of Psoriasis Therapeutics include Astellas Pharma Inc., AstraZeneca plc, Boehringer Ingelheim GmbH, F. Hofffmann-La Roche, and GlaxoSmithKline plc, etc. In terms of revenue, the global top four players hold a share over % in 2021.

Market segmentation

Psoriasis Therapeutics market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers

TNF Inhibitors

PDE4 Inhibitors

Interleukin Blockers

Others

Market segment by Application, can be divided into

Oral

Parenteral

Topical

Market segment by players, this report covers

Astellas Pharma Inc.

AstraZeneca plc

Boehringer Ingelheim GmbH

F. Hofffmann-La Roche

GlaxoSmithKline plc

Merck & Co., Inc.

Valeant Pharmaceuticals International, Inc.

Biocon Limited

Eli Lilly and Company

G & W Laboratories Inc.

Market segment by regions, regional analysis covers

North America (United States, Canada, and Mexico)

Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)

Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)

South America (Brazil, Argentina, Rest of South America)

Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

The content of the study subjects, includes a total of 12 chapters:

Chapter 1, to describe Psoriasis Therapeutics product scope, market overview, market opportunities, market driving force and market risks.

Chapter 2, to profile the top players of Psoriasis Therapeutics, with revenue, gross margin and global market share of Psoriasis Therapeutics from 2019 to 2022.

Chapter 3, the Psoriasis Therapeutics competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.

Chapter 4 and 5, to segment the market size by Type and application, with revenue and growth rate by Type, application, from 2017 to 2028.

Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2017 to 2022.and Psoriasis Therapeutics market forecast, by regions, type and application, with revenue, from 2023 to 2028.

Chapter 11 and 12, to describe Psoriasis Therapeutics research findings and conclusion, appendix and data source.

Frequently Asked Questions

What is scope of the report?

The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.

What are the significant segments operating in the market?

Market is segmented on the basis:

By Type
By Application
By Region
By Country
By Manufacturer

What are the vital market dynamics?

The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.

What does a company profile includes?

The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.

1 Market Overview

1.1 Product Overview and Scope of Psoriasis Therapeutics

1.2 Classification of Psoriasis Therapeutics by Type

1.2.1 Overview: Global Psoriasis Therapeutics Market Size by Type: 2017 Versus 2021 Versus 2028

1.2.2 Global Psoriasis Therapeutics Revenue Market Share by Type in 2021

1.2.3 TNF Inhibitors

1.2.4 PDE4 Inhibitors

1.2.5 Interleukin Blockers

1.2.6 Others

1.3 Global Psoriasis Therapeutics Market by Application

1.3.1 Overview: Global Psoriasis Therapeutics Market Size by Application: 2017 Versus 2021 Versus 2028

1.3.2 Oral

1.3.3 Parenteral

1.3.4 Topical

1.4 Global Psoriasis Therapeutics Market Size & Forecast

1.5 Global Psoriasis Therapeutics Market Size and Forecast by Region

1.5.1 Global Psoriasis Therapeutics Market Size by Region: 2017 VS 2021 VS 2028

1.5.2 Global Psoriasis Therapeutics Market Size by Region, (2017-2022)

1.5.3 North America Psoriasis Therapeutics Market Size and Prospect (2017-2028)

1.5.4 Europe Psoriasis Therapeutics Market Size and Prospect (2017-2028)

1.5.5 Asia-Pacific Psoriasis Therapeutics Market Size and Prospect (2017-2028)

1.5.6 South America Psoriasis Therapeutics Market Size and Prospect (2017-2028)

1.5.7 Middle East and Africa Psoriasis Therapeutics Market Size and Prospect (2017-2028)

1.6 Market Drivers, Restraints and Trends

1.6.1 Psoriasis Therapeutics Market Drivers

1.6.2 Psoriasis Therapeutics Market Restraints

1.6.3 Psoriasis Therapeutics Trends Analysis

2 Company Profiles

2.1 Astellas Pharma Inc.

2.1.1 Astellas Pharma Inc. Details

2.1.2 Astellas Pharma Inc. Major Business

2.1.3 Astellas Pharma Inc. Psoriasis Therapeutics Product and Solutions

2.1.4 Astellas Pharma Inc. Psoriasis Therapeutics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.1.5 Astellas Pharma Inc. Recent Developments and Future Plans

2.2 AstraZeneca plc

2.2.1 AstraZeneca plc Details

2.2.2 AstraZeneca plc Major Business

2.2.3 AstraZeneca plc Psoriasis Therapeutics Product and Solutions

2.2.4 AstraZeneca plc Psoriasis Therapeutics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.2.5 AstraZeneca plc Recent Developments and Future Plans

2.3 Boehringer Ingelheim GmbH

2.3.1 Boehringer Ingelheim GmbH Details

2.3.2 Boehringer Ingelheim GmbH Major Business

2.3.3 Boehringer Ingelheim GmbH Psoriasis Therapeutics Product and Solutions

2.3.4 Boehringer Ingelheim GmbH Psoriasis Therapeutics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.3.5 Boehringer Ingelheim GmbH Recent Developments and Future Plans

2.4 F. Hofffmann-La Roche

2.4.1 F. Hofffmann-La Roche Details

2.4.2 F. Hofffmann-La Roche Major Business

2.4.3 F. Hofffmann-La Roche Psoriasis Therapeutics Product and Solutions

2.4.4 F. Hofffmann-La Roche Psoriasis Therapeutics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.4.5 F. Hofffmann-La Roche Recent Developments and Future Plans

2.5 GlaxoSmithKline plc

2.5.1 GlaxoSmithKline plc Details

2.5.2 GlaxoSmithKline plc Major Business

2.5.3 GlaxoSmithKline plc Psoriasis Therapeutics Product and Solutions

2.5.4 GlaxoSmithKline plc Psoriasis Therapeutics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.5.5 GlaxoSmithKline plc Recent Developments and Future Plans

2.6 Merck & Co., Inc.

2.6.1 Merck & Co., Inc. Details

2.6.2 Merck & Co., Inc. Major Business

2.6.3 Merck & Co., Inc. Psoriasis Therapeutics Product and Solutions

2.6.4 Merck & Co., Inc. Psoriasis Therapeutics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.6.5 Merck & Co., Inc. Recent Developments and Future Plans

2.7 Valeant Pharmaceuticals International, Inc.

2.7.1 Valeant Pharmaceuticals International, Inc. Details

2.7.2 Valeant Pharmaceuticals International, Inc. Major Business

2.7.3 Valeant Pharmaceuticals International, Inc. Psoriasis Therapeutics Product and Solutions

2.7.4 Valeant Pharmaceuticals International, Inc. Psoriasis Therapeutics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.7.5 Valeant Pharmaceuticals International, Inc. Recent Developments and Future Plans

2.8 Biocon Limited

2.8.1 Biocon Limited Details

2.8.2 Biocon Limited Major Business

2.8.3 Biocon Limited Psoriasis Therapeutics Product and Solutions

2.8.4 Biocon Limited Psoriasis Therapeutics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.8.5 Biocon Limited Recent Developments and Future Plans

2.9 Eli Lilly and Company

2.9.1 Eli Lilly and Company Details

2.9.2 Eli Lilly and Company Major Business

2.9.3 Eli Lilly and Company Psoriasis Therapeutics Product and Solutions

2.9.4 Eli Lilly and Company Psoriasis Therapeutics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.9.5 Eli Lilly and Company Recent Developments and Future Plans

2.10 G & W Laboratories Inc.

2.10.1 G & W Laboratories Inc. Details

2.10.2 G & W Laboratories Inc. Major Business

2.10.3 G & W Laboratories Inc. Psoriasis Therapeutics Product and Solutions

2.10.4 G & W Laboratories Inc. Psoriasis Therapeutics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.10.5 G & W Laboratories Inc. Recent Developments and Future Plans

3 Market Competition, by Players

3.1 Global Psoriasis Therapeutics Revenue and Share by Players (2019, 2020, 2021, and 2022)

3.2 Market Concentration Rate

3.2.1 Top 3 Psoriasis Therapeutics Players Market Share in 2021

3.2.2 Top 10 Psoriasis Therapeutics Players Market Share in 2021

3.2.3 Market Competition Trend

3.3 Psoriasis Therapeutics Players Head Office, Products and Services Provided

3.4 Psoriasis Therapeutics Mergers & Acquisitions

3.5 Psoriasis Therapeutics New Entrants and Expansion Plans

4 Market Size Segment by Type

4.1 Global Psoriasis Therapeutics Revenue and Market Share by Type (2017-2022)

4.2 Global Psoriasis Therapeutics Market Forecast by Type (2023-2028)

5 Market Size Segment by Application

5.1 Global Psoriasis Therapeutics Revenue Market Share by Application (2017-2022)

5.2 Global Psoriasis Therapeutics Market Forecast by Application (2023-2028)

6 North America by Country, by Type, and by Application

6.1 North America Psoriasis Therapeutics Revenue by Type (2017-2028)

6.2 North America Psoriasis Therapeutics Revenue by Application (2017-2028)

6.3 North America Psoriasis Therapeutics Market Size by Country

6.3.1 North America Psoriasis Therapeutics Revenue by Country (2017-2028)

6.3.2 United States Psoriasis Therapeutics Market Size and Forecast (2017-2028)

6.3.3 Canada Psoriasis Therapeutics Market Size and Forecast (2017-2028)

6.3.4 Mexico Psoriasis Therapeutics Market Size and Forecast (2017-2028)

7 Europe by Country, by Type, and by Application

7.1 Europe Psoriasis Therapeutics Revenue by Type (2017-2028)

7.2 Europe Psoriasis Therapeutics Revenue by Application (2017-2028)

7.3 Europe Psoriasis Therapeutics Market Size by Country

7.3.1 Europe Psoriasis Therapeutics Revenue by Country (2017-2028)

7.3.2 Germany Psoriasis Therapeutics Market Size and Forecast (2017-2028)

7.3.3 France Psoriasis Therapeutics Market Size and Forecast (2017-2028)

7.3.4 United Kingdom Psoriasis Therapeutics Market Size and Forecast (2017-2028)

7.3.5 Russia Psoriasis Therapeutics Market Size and Forecast (2017-2028)

7.3.6 Italy Psoriasis Therapeutics Market Size and Forecast (2017-2028)

8 Asia-Pacific by Region, by Type, and by Application

8.1 Asia-Pacific Psoriasis Therapeutics Revenue by Type (2017-2028)

8.2 Asia-Pacific Psoriasis Therapeutics Revenue by Application (2017-2028)

8.3 Asia-Pacific Psoriasis Therapeutics Market Size by Region

8.3.1 Asia-Pacific Psoriasis Therapeutics Revenue by Region (2017-2028)

8.3.2 China Psoriasis Therapeutics Market Size and Forecast (2017-2028)

8.3.3 Japan Psoriasis Therapeutics Market Size and Forecast (2017-2028)

8.3.4 South Korea Psoriasis Therapeutics Market Size and Forecast (2017-2028)

8.3.5 India Psoriasis Therapeutics Market Size and Forecast (2017-2028)

8.3.6 Southeast Asia Psoriasis Therapeutics Market Size and Forecast (2017-2028)

8.3.7 Australia Psoriasis Therapeutics Market Size and Forecast (2017-2028)

9 South America by Country, by Type, and by Application

9.1 South America Psoriasis Therapeutics Revenue by Type (2017-2028)

9.2 South America Psoriasis Therapeutics Revenue by Application (2017-2028)

9.3 South America Psoriasis Therapeutics Market Size by Country

9.3.1 South America Psoriasis Therapeutics Revenue by Country (2017-2028)

9.3.2 Brazil Psoriasis Therapeutics Market Size and Forecast (2017-2028)

9.3.3 Argentina Psoriasis Therapeutics Market Size and Forecast (2017-2028)

10 Middle East & Africa by Country, by Type, and by Application

10.1 Middle East & Africa Psoriasis Therapeutics Revenue by Type (2017-2028)

10.2 Middle East & Africa Psoriasis Therapeutics Revenue by Application (2017-2028)

10.3 Middle East & Africa Psoriasis Therapeutics Market Size by Country

10.3.1 Middle East & Africa Psoriasis Therapeutics Revenue by Country (2017-2028)

10.3.2 Turkey Psoriasis Therapeutics Market Size and Forecast (2017-2028)

10.3.3 Saudi Arabia Psoriasis Therapeutics Market Size and Forecast (2017-2028)

10.3.4 UAE Psoriasis Therapeutics Market Size and Forecast (2017-2028)

11 Research Findings and Conclusion

12 Appendix

12.1 Methodology

12.2 Research Process and Data Source

12.3 Disclaimer

List of Tables

Table 1. Global Psoriasis Therapeutics Revenue by Type, (USD Million), 2017 VS 2021 VS 2028

Table 2. Global Psoriasis Therapeutics Revenue by Application, (USD Million), 2017 VS 2021 VS 2028

Table 3. Global Market Psoriasis Therapeutics Revenue (Million USD) Comparison by Region (2017 VS 2021 VS 2028)

Table 4. Global Psoriasis Therapeutics Revenue (USD Million) by Region (2017-2022)

Table 5. Global Psoriasis Therapeutics Revenue Market Share by Region (2023-2028)

Table 6. Astellas Pharma Inc. Corporate Information, Head Office, and Major Competitors

Table 7. Astellas Pharma Inc. Major Business

Table 8. Astellas Pharma Inc. Psoriasis Therapeutics Product and Solutions

Table 9. Astellas Pharma Inc. Psoriasis Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 10. AstraZeneca plc Corporate Information, Head Office, and Major Competitors

Table 11. AstraZeneca plc Major Business

Table 12. AstraZeneca plc Psoriasis Therapeutics Product and Solutions

Table 13. AstraZeneca plc Psoriasis Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 14. Boehringer Ingelheim GmbH Corporate Information, Head Office, and Major Competitors

Table 15. Boehringer Ingelheim GmbH Major Business

Table 16. Boehringer Ingelheim GmbH Psoriasis Therapeutics Product and Solutions

Table 17. Boehringer Ingelheim GmbH Psoriasis Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 18. F. Hofffmann-La Roche Corporate Information, Head Office, and Major Competitors

Table 19. F. Hofffmann-La Roche Major Business

Table 20. F. Hofffmann-La Roche Psoriasis Therapeutics Product and Solutions

Table 21. F. Hofffmann-La Roche Psoriasis Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 22. GlaxoSmithKline plc Corporate Information, Head Office, and Major Competitors

Table 23. GlaxoSmithKline plc Major Business

Table 24. GlaxoSmithKline plc Psoriasis Therapeutics Product and Solutions

Table 25. GlaxoSmithKline plc Psoriasis Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 26. Merck & Co., Inc. Corporate Information, Head Office, and Major Competitors

Table 27. Merck & Co., Inc. Major Business

Table 28. Merck & Co., Inc. Psoriasis Therapeutics Product and Solutions

Table 29. Merck & Co., Inc. Psoriasis Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 30. Valeant Pharmaceuticals International, Inc. Corporate Information, Head Office, and Major Competitors

Table 31. Valeant Pharmaceuticals International, Inc. Major Business

Table 32. Valeant Pharmaceuticals International, Inc. Psoriasis Therapeutics Product and Solutions

Table 33. Valeant Pharmaceuticals International, Inc. Psoriasis Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 34. Biocon Limited Corporate Information, Head Office, and Major Competitors

Table 35. Biocon Limited Major Business

Table 36. Biocon Limited Psoriasis Therapeutics Product and Solutions

Table 37. Biocon Limited Psoriasis Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 38. Eli Lilly and Company Corporate Information, Head Office, and Major Competitors

Table 39. Eli Lilly and Company Major Business

Table 40. Eli Lilly and Company Psoriasis Therapeutics Product and Solutions

Table 41. Eli Lilly and Company Psoriasis Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 42. G & W Laboratories Inc. Corporate Information, Head Office, and Major Competitors

Table 43. G & W Laboratories Inc. Major Business

Table 44. G & W Laboratories Inc. Psoriasis Therapeutics Product and Solutions

Table 45. G & W Laboratories Inc. Psoriasis Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 46. Global Psoriasis Therapeutics Revenue (USD Million) by Players (2019, 2020, 2021, and 2022)

Table 47. Global Psoriasis Therapeutics Revenue Share by Players (2019, 2020, 2021, and 2022)

Table 48. Breakdown of Psoriasis Therapeutics by Company Type (Tier 1, Tier 2 and Tier 3)

Table 49. Psoriasis Therapeutics Players Head Office, Products and Services Provided

Table 50. Psoriasis Therapeutics Mergers & Acquisitions in the Past Five Years

Table 51. Psoriasis Therapeutics New Entrants and Expansion Plans

Table 52. Global Psoriasis Therapeutics Revenue (USD Million) by Type (2017-2022)

Table 53. Global Psoriasis Therapeutics Revenue Share by Type (2017-2022)

Table 54. Global Psoriasis Therapeutics Revenue Forecast by Type (2023-2028)

Table 55. Global Psoriasis Therapeutics Revenue by Application (2017-2022)

Table 56. Global Psoriasis Therapeutics Revenue Forecast by Application (2023-2028)

Table 57. North America Psoriasis Therapeutics Revenue by Type (2017-2022) & (USD Million)

Table 58. North America Psoriasis Therapeutics Revenue by Type (2023-2028) & (USD Million)

Table 59. North America Psoriasis Therapeutics Revenue by Application (2017-2022) & (USD Million)

Table 60. North America Psoriasis Therapeutics Revenue by Application (2023-2028) & (USD Million)

Table 61. North America Psoriasis Therapeutics Revenue by Country (2017-2022) & (USD Million)

Table 62. North America Psoriasis Therapeutics Revenue by Country (2023-2028) & (USD Million)

Table 63. Europe Psoriasis Therapeutics Revenue by Type (2017-2022) & (USD Million)

Table 64. Europe Psoriasis Therapeutics Revenue by Type (2023-2028) & (USD Million)

Table 65. Europe Psoriasis Therapeutics Revenue by Application (2017-2022) & (USD Million)

Table 66. Europe Psoriasis Therapeutics Revenue by Application (2023-2028) & (USD Million)

Table 67. Europe Psoriasis Therapeutics Revenue by Country (2017-2022) & (USD Million)

Table 68. Europe Psoriasis Therapeutics Revenue by Country (2023-2028) & (USD Million)

Table 69. Asia-Pacific Psoriasis Therapeutics Revenue by Type (2017-2022) & (USD Million)

Table 70. Asia-Pacific Psoriasis Therapeutics Revenue by Type (2023-2028) & (USD Million)

Table 71. Asia-Pacific Psoriasis Therapeutics Revenue by Application (2017-2022) & (USD Million)

Table 72. Asia-Pacific Psoriasis Therapeutics Revenue by Application (2023-2028) & (USD Million)

Table 73. Asia-Pacific Psoriasis Therapeutics Revenue by Region (2017-2022) & (USD Million)

Table 74. Asia-Pacific Psoriasis Therapeutics Revenue by Region (2023-2028) & (USD Million)

Table 75. South America Psoriasis Therapeutics Revenue by Type (2017-2022) & (USD Million)

Table 76. South America Psoriasis Therapeutics Revenue by Type (2023-2028) & (USD Million)

Table 77. South America Psoriasis Therapeutics Revenue by Application (2017-2022) & (USD Million)

Table 78. South America Psoriasis Therapeutics Revenue by Application (2023-2028) & (USD Million)

Table 79. South America Psoriasis Therapeutics Revenue by Country (2017-2022) & (USD Million)

Table 80. South America Psoriasis Therapeutics Revenue by Country (2023-2028) & (USD Million)

Table 81. Middle East & Africa Psoriasis Therapeutics Revenue by Type (2017-2022) & (USD Million)

Table 82. Middle East & Africa Psoriasis Therapeutics Revenue by Type (2023-2028) & (USD Million)

Table 83. Middle East & Africa Psoriasis Therapeutics Revenue by Application (2017-2022) & (USD Million)

Table 84. Middle East & Africa Psoriasis Therapeutics Revenue by Application (2023-2028) & (USD Million)

Table 85. Middle East & Africa Psoriasis Therapeutics Revenue by Country (2017-2022) & (USD Million)

Table 86. Middle East & Africa Psoriasis Therapeutics Revenue by Country (2023-2028) & (USD Million)

List of Figures

Figure 1. Psoriasis Therapeutics Picture

Figure 2. Global Psoriasis Therapeutics Revenue Market Share by Type in 2021

Figure 3. TNF Inhibitors

Figure 4. PDE4 Inhibitors

Figure 5. Interleukin Blockers

Figure 6. Others

Figure 7. Psoriasis Therapeutics Revenue Market Share by Application in 2021

Figure 8. Oral Picture

Figure 9. Parenteral Picture

Figure 10. Topical Picture

Figure 11. Global Psoriasis Therapeutics Market Size, (USD Million): 2017 VS 2021 VS 2028

Figure 12. Global Psoriasis Therapeutics Revenue and Forecast (2017-2028) & (USD Million)

Figure 13. Global Psoriasis Therapeutics Revenue Market Share by Region (2017-2028)

Figure 14. Global Psoriasis Therapeutics Revenue Market Share by Region in 2021

Figure 15. North America Psoriasis Therapeutics Revenue (USD Million) and Growth Rate (2017-2028)

Figure 16. Europe Psoriasis Therapeutics Revenue (USD Million) and Growth Rate (2017-2028)

Figure 17. Asia-Pacific Psoriasis Therapeutics Revenue (USD Million) and Growth Rate (2017-2028)

Figure 18. South America Psoriasis Therapeutics Revenue (USD Million) and Growth Rate (2017-2028)

Figure 19. Middle East and Africa Psoriasis Therapeutics Revenue (USD Million) and Growth Rate (2017-2028)

Figure 20. Psoriasis Therapeutics Market Drivers

Figure 21. Psoriasis Therapeutics Market Restraints

Figure 22. Psoriasis Therapeutics Market Trends

Figure 23. Astellas Pharma Inc. Recent Developments and Future Plans

Figure 24. AstraZeneca plc Recent Developments and Future Plans

Figure 25. Boehringer Ingelheim GmbH Recent Developments and Future Plans

Figure 26. F. Hofffmann-La Roche Recent Developments and Future Plans

Figure 27. GlaxoSmithKline plc Recent Developments and Future Plans

Figure 28. Merck & Co., Inc. Recent Developments and Future Plans

Figure 29. Valeant Pharmaceuticals International, Inc. Recent Developments and Future Plans

Figure 30. Biocon Limited Recent Developments and Future Plans

Figure 31. Eli Lilly and Company Recent Developments and Future Plans

Figure 32. G & W Laboratories Inc. Recent Developments and Future Plans

Figure 33. Global Psoriasis Therapeutics Revenue Share by Players in 2021

Figure 34. Psoriasis Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2021

Figure 35. Global Top 3 Players Psoriasis Therapeutics Revenue Market Share in 2021

Figure 36. Global Top 10 Players Psoriasis Therapeutics Revenue Market Share in 2021

Figure 37. Key Players Market Share Trend (Top 3 Market Share: 2020 VS 2021 VS 2022)

Figure 38. Global Psoriasis Therapeutics Revenue Share by Type in 2021

Figure 39. Global Psoriasis Therapeutics Market Share Forecast by Type (2023-2028)

Figure 40. Global Psoriasis Therapeutics Revenue Share by Application in 2021

Figure 41. Global Psoriasis Therapeutics Market Share Forecast by Application (2023-2028)

Figure 42. North America Psoriasis Therapeutics Sales Market Share by Type (2017-2028)

Figure 43. North America Psoriasis Therapeutics Sales Market Share by Application (2017-2028)

Figure 44. North America Psoriasis Therapeutics Revenue Market Share by Country (2017-2028)

Figure 45. United States Psoriasis Therapeutics Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 46. Canada Psoriasis Therapeutics Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 47. Mexico Psoriasis Therapeutics Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 48. Europe Psoriasis Therapeutics Sales Market Share by Type (2017-2028)

Figure 49. Europe Psoriasis Therapeutics Sales Market Share by Application (2017-2028)

Figure 50. Europe Psoriasis Therapeutics Revenue Market Share by Country (2017-2028)

Figure 51. Germany Psoriasis Therapeutics Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 52. France Psoriasis Therapeutics Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 53. United Kingdom Psoriasis Therapeutics Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 54. Russia Psoriasis Therapeutics Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 55. Italy Psoriasis Therapeutics Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 56. Asia-Pacific Psoriasis Therapeutics Sales Market Share by Type (2017-2028)

Figure 57. Asia-Pacific Psoriasis Therapeutics Sales Market Share by Application (2017-2028)

Figure 58. Asia-Pacific Psoriasis Therapeutics Revenue Market Share by Region (2017-2028)

Figure 59. China Psoriasis Therapeutics Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 60. Japan Psoriasis Therapeutics Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 61. South Korea Psoriasis Therapeutics Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 62. India Psoriasis Therapeutics Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 63. Southeast Asia Psoriasis Therapeutics Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 64. Australia Psoriasis Therapeutics Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 65. South America Psoriasis Therapeutics Sales Market Share by Type (2017-2028)

Figure 66. South America Psoriasis Therapeutics Sales Market Share by Application (2017-2028)

Figure 67. South America Psoriasis Therapeutics Revenue Market Share by Country (2017-2028)

Figure 68. Brazil Psoriasis Therapeutics Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 69. Argentina Psoriasis Therapeutics Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 70. Middle East and Africa Psoriasis Therapeutics Sales Market Share by Type (2017-2028)

Figure 71. Middle East and Africa Psoriasis Therapeutics Sales Market Share by Application (2017-2028)

Figure 72. Middle East and Africa Psoriasis Therapeutics Revenue Market Share by Country (2017-2028)

Figure 73. Turkey Psoriasis Therapeutics Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 74. Saudi Arabia Psoriasis Therapeutics Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 75. UAE Psoriasis Therapeutics Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 76. Methodology

Figure 77. Research Process and Data Source

License Type

Quick Contact

Our Clients

Need Help?

Please contact directly on our US and India numbers

+1-201-465-4211

Please feel free to write an email to us or to use our electronic ticketing system.

sales@marketquest.biz